Cabot (CBT) Fundamental Analysis: Revenue, Earnings & Valuation

6.67 / 10

Outperform

Fundamental analysis rates CBT Outperform with a 6.67 score. Strengths include a healthy current ratio (1.61), solid equity multiplier (2.46), favorable cost‑of‑sales ratio and low long‑term debt to working capital. Weaknesses are negative cash‑up and declining operating cash‑flow growth, tempering the outlook.

Analysis Checks(9/10)

Net cash flow from operating activities per share (YoY growth rate %)

Value-1.26

Score2/3

Weight6.45%

1M Return3.49%

Equity multiplier

Value2.46

Score3/3

Weight10.53%

1M Return5.48%

Profit-MV

Value0.03

Score2/3

Weight9.22%

1M Return4.34%

Net income-Revenue

Value-0.68

Score3/3

Weight18.27%

1M Return8.30%

Net cash flow from operating activities (YoY growth rate %)

Value-3.90

Score2/3

Weight6.82%

1M Return3.56%

Cash-UP

Value-0.25

Score1/3

Weight-0.54%

1M Return-0.35%

Long-term debt to working capital ratio (%)

Value1.98

Score3/3

Weight12.04%

1M Return6.17%

Cost of sales ratio (%)

Value74.68

Score3/3

Weight12.18%

1M Return6.54%

Equity multiplier (DuPont analysis %)

Value2.54

Score3/3

Weight12.65%

1M Return6.64%

Current ratio

Value1.61

Score3/3

Weight12.39%

1M Return6.27%

Is CBT undervalued or overvalued?

CBT scores 6.67/10 on fundamentals and holds a Discounted valuation at present. Backed by its 4.25% ROE, 9.81% net margin, 12.21 P/E ratio, 2.20 P/B ratio, and -24.21% earnings growth, these metrics solidify its Outperform investment rating.